PRQR
#3541
ProQR Therapeutics N.V. - Ordinary Shares
2.1 3 USD
-0.07%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-6.99%
Monatliche Änderung
+23.12%
6 month change
+38.31%
Jahresänderung
-4.91%
Vorheriger Schlusskurs
2.2 9
Open
2.1 3
Tief
2.1 3
Hoch
2.1 3
Volumen
19
Financials
- Market Capitalization 224.42 M
- Employee 187
- Founded 2012
- CEO Daniel A. de Boer
- Website www.proqr.com
- Headquarter Netherlands
- FIGI UNKNOWN
- Industry Biotechnologie
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 3531 |  TARA Protara Therapeutics, Inc. - Common Stock | 3.86 USD | +1.05% | 0.00% | -2.03% | +23.32% | 228.11 M USD | ||
| 3532 |  RNA Atrium Therapeutics, Inc. - Common Stock | 13.32 USD | -2.35% | -2.92% | +16.33% | -81.06% | 227.85 M USD | ||
| 3562 |  KROS Keros Therapeutics, Inc. - common stock | 11.08 USD | +0.45% | +2.31% | +9.06% | -26.62% | 219.69 M USD | ||
| 3564 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 14.95 USD | -4.59% | -14.38% | +10.74% | +28.88% | 219.44 M USD |